Peak6 Investments LLC Exelixis, Inc. Put Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $437,289 - $537,186	-21,300 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $399,096 - $601,680	-27,600 Reduced 56.44%	21,300 $367,000
Q4 2019 Feb 13, 2020	SELL	$15.15 - $18.89 $592,365 - $738,599	-39,100 Reduced 44.43%	48,900 $862,000
Q3 2019 Nov 08, 2019	BUY	$17.68 - $22.65 $429,624 - $550,395	24,300 Added 38.15%	88,000 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $1.16 Million - $1.51 Million	61,100 Added 2350.0%	63,700 $1.36 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $50,960 - $64,376	2,600 New	2,600 $62,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.